Delivery Order SPE2DB22D3019-SPE2DB26FK2TA
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Briviact 100 mg tablets (60-count packaging). This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,706.39 and an ultimate completion date of August 15, 2025. The contract is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $5,677.12 to AmerisourceBergen Drug Corp for the supply of Briviact 100 mg tablets (60-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitive, non-set-aside award employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $285,550 to AmerisourceBergen Drug Corp for the supply of Briviact 50 mg tablets (60-count units). This competitively awarded, firm fixed-price delivery order was issued on October 22, 2025, with an ultimate completion date of October 23, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $5,136.01 to AmerisourceBergen Drug Corp for the supply of Briviact 50 mg tablets (60-count packaging) with a completion date of July 30, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical products will be delivered to the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,987.19 to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Briviact 50 mg tablets (60-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 15, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among qualified...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,072.23 for Briviact 100 mg tablets (60-count) with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and reflects AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical procurement system. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $1,135.62 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Briviact 50 mg tablets (60-count packaging). This is a firm fixed price delivery order with no set-aside designation, executed under competitive procedures. The contract specifies a place of performance in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. The order carries an ultimate completion date of September...
- The Defense Logistics Agency awarded a delivery order valued at $1,624.15 to AmerisourceBergen Drug Corp for Briviact 75 mg tablets (60-count units) on July 22, 2025, with completion scheduled for July 23, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Briviact 50 mg tablets (60-count units) under a firm fixed-price contract valued at $2,538.23. This non-set-aside competitive award is scheduled for completion by August 25, 2025, with performance to take place at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on September 18, 2025. This firm fixed-price delivery order, valued at $1,857.38, covers the supply of Briviact 100 mg tablets (60-count units) and is scheduled for completion by September 19, 2025. The award was made through open competition with no set-aside designation. This delivery order is issued under...
- SPE2DB22D3019Indefinite Delivery Contract
- SPE2DB22D3019-SPE2DB26FK2TADelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Briviact 50 mg tablets in a 60-count package. This competitively awarded, firm fixed-price delivery order has a ceiling value of $6,025.11 and was awarded on October 27, 2025, with an ultimate completion date of October 28, 2025. The award was executed without a set-aside designation, demonstrating AmerisourceBergen's competitive standing in federal pharmaceutical procurement. The place of performance is located in Conshohocken, PA, where the company maintains its corporate operations. This delivery order represents a task under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. As the prime contractor under this comprehensive global pharmaceutical support vehicle, AmerisourceBergen supplies an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including critical medications, vaccines, and medical devices across multiple therapeutic domains. The company serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract vehicle, positioning it as a critical vendor for federal medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 10/27/25 |